Baxter announced that it has declared a quarterly dividend of $0.29 per Company common share.
This represents an increase of approximately 12% over the previous quarterly rate of $0.26 per share. The dividend is payable on January 5, 2010, to shareholders of record as of the close of business on December 10, 2009.
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto
Baxter International was found by the FDA to have failed to follow good manufacturing practices as outlined in a letter to the company.
The FDA said it inspected Baxter plants and corporate offices in Illinois, California and Germany between April and June 2009 and found the company has failed its commitment to quality. A representative for the company couldn't immediately be reached for comment.
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto
Baxter International reported earnings of $0.87 per share versus $0.74 per share for the year ago quarter. Sales for the quarter were $3.15 billion which is flat for the year ago quarter.
Baxter attributes the earnings growth on flat sales to lowered expenses, improved margins, and a stock buyback program.
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto
Advertisement